InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
LPS-EK (LPS from E. coli K12) | Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in... | 2020 | Cells | Köse-Vogel N. et al. | DOI: 10.3390/cells9010079 |
HKLM | Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in... | 2020 | Cells | Köse-Vogel N. et al. | DOI: 10.3390/cells9010079 |
Bafilomycin A1 | Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in... | 2020 | Cells | Köse-Vogel N. et al. | DOI: 10.3390/cells9010079 |
QUANTI-Blue™ | Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in... | 2020 | Cells | Köse-Vogel N. et al. | DOI: 10.3390/cells9010079 |
Pam3CSK4 | Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in... | 2020 | Cells | Köse-Vogel N. et al. | DOI: 10.3390/cells9010079 |
ATP | Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in... | 2020 | Cells | Köse-Vogel N. et al. | DOI: 10.3390/cells9010079 |
5'ppp-dsRNA | Tripodal RNA with 3′ Overhangs Prevents RIG-I-Mediated Innate Immune Response. | 2019 | Nucleic Acid Ther. | Kang Y.G. et al. | DOI: 10.1089/nat.2019.0778 |
EndoFit™ OVA protein | Novel colloidal associations of soyasaponins and lipid components (DPPC, chol... | 2019 | Vaccine. | de Groot C. et al. | DOI: 10.1016/j.vaccine.2019.07.020 |
pVITRO1-MCS | AGR2, a unique tumor-associated antigen, is a promising candidate for antibod... | 2019 | Oncotarget. | Liu A.Y. et al. | DOI: 10.18632/oncotarget.26945 |
ODN 1668 - TLR9 ligand | Cargo-less nanoparticles program innate immune cell responses to toll-like re... | 2019 | Biomaterials. | Casey L.M. et al. | DOI: 10.1016/j.biomaterials.2019.119333 |
Anti-mouse Dectin-1 (CLEC7A) antibody | Unique microglia expression profile in developing white matter. | 2019 | BMC Res Notes. | Staszewski O. & Hagemeyer N. | DOI: 10.1186/s13104-019-4410-1 |
ODN 1668 - TLR9 ligand | Cutting Edge: TAK1 Safeguards Macrophages against Proinflammatory Cell Death. | 2019 | J Immunol. | Sanjo H. et al. | DOI: 10.4049/jimmunol.1900202 |
HEK-Blue™ Null2 Cells | Phagocytosis of spherical and ellipsoidal micronetwork colloids from crosslin... | 2019 | Int J Pharm. | Friess F. et al. | DOI: 10.1016/j.ijpharm.2019.118461 |
LPS-EB Biotin | Inhibition of myeloid differentiation factor 2 by baicalein protects against ... | 2019 | Phytomedicine. | Chen H. et al. | DOI: 10.1016/j.phymed.2019.152997 |
Mouse TLR1-9 Agonist kit | The cooperative induction of macrophage activation by fucoidan derived from C... | 2019 | BBRC | Miyazaki Y. et al. | DOI: 10.1016/j.bbrc.2019.06.010 |
ODN 2395 - TLR9 ligand | Interferon regulatory factor 1 eliminates mycobacteria by suppressing p70 S6 ... | 2019 | J Infect. | Zhou X. et al. | DOI: 10.1016/j.jinf.2019.06.007 |
Quil-A® adjuvant | HPV16 E7-Driven Epithelial Hyperplasia Promotes Impaired Antigen Presentation... | 2019 | J Invest Dermatol. | Bashaw A.A. et al. | DOI: 10.1016/j.jid.2019.03.1162 |
ODN 2006 (ODN 7909) | Targeting IRAK4 disrupts inflammatory pathways and delays tumor development i... | 2020 | Leukemia. | Giménez N. et al. | DOI: 10.1038/s41375-019-0507-8 |
ssRNA40/LyoVec™ | Targeting IRAK4 disrupts inflammatory pathways and delays tumor development i... | 2020 | Leukemia. | Giménez N. et al. | DOI: 10.1038/s41375-019-0507-8 |
Human EGFR Antibody - Cetuximab biosimilar | Cabozantinib induces PUMA-dependent apoptosis in colon cancer cells via AKT/G... | 2019 | Cancer Gene Ther. | Yang S. et al. | DOI: 10.1038/s41417-019-0098-6 |